[1] Gurnee EA, Johansen ML, Phung TL, et al.Pediatric maculopapular cutaneous mastocytosis: Retrospective review of signs, symptoms, and associated conditions[J]. Pediatr Dermatol, 2021, 38(1): 159-163.
[2] Demain JG, Carter MC.Urticaria Pigmentosa in a Child: Special Considerations for Vaccines, Dietary Concerns, and Other Management[J]. J Allergy Clin Immunol Pract, 2021,9(4): 1761-1762.
[3] Maehara E, Kido-Nakahara M, Ito T, et al.Darier's sign in urticaria pigmentosa-significance of perivascular eosinophilic infiltration[J]. Allergol Int, 2018, 67(4): 532-534.
[4] 王晓华,林尔艺,饶朗. 色素性荨麻疹13例临床分析[J]. 中国皮肤性病学杂志,2017,31(3): 288-289, 314.
[5] Sammut J, Mercieca L, Boffa MM, et al.Palmoplantar maculopapular cutaneous mastocytosis[J]. Int J Dermatol, 2019, 58(4): E79-E80.
[6] Le M, Miedzybrodzki B, Olynych T, et al.Natural history and treatment of cutaneous and systemic mastocytosis[J]. Postgrad Med, 2017,129(8): 896-901.
[7] Tampouratzi L, Kanni T, Katsantonis J, et al.Maculopapular Cutaneous Mastocytosis Successfully Treated with Omalizumab[J]. Acta Dermatovenerol Croat, 2021, 291(1): 60-61.
[8] Johansen ML, Lawley LP.Assessing vaccination reactions in pediatric patients with maculopapular cutaneous mastocytosis[J]. Pediatr Dermatol, 2021, 38(2): 502-503. |
